PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
S F Paul Man Selected Research
Chronic Obstructive Pulmonary Disease (COPD)
06/2008
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
06/2008
Biomarkers in COPD: are we there yet?
01/2008
Interleukin-6: a red herring or a real catch in COPD?
07/2007
The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.
03/2007
Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
01/2007
Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD.
09/2006
Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
01/2006
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
01/2005
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis.
01/2005
Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.
01/2005
Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
10/2004
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
01/2004
Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
07/2003
Inhaled glucocorticoids in COPD: immortal time bias.
01/2003
Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.
Articles by Research Topic
Disease
15
Chronic Obstructive Pulmonary Disease (COPD)
06/2008 - 01/2003
4
Inflammation
06/2008 - 10/2004
3
Lung Neoplasms (Lung Cancer)
09/2008 - 03/2006
2
Pneumonia (Pneumonitis)
07/2008 - 02/2005
1
Asthma (Bronchial Asthma)
07/2003
Drug/Important Bio-Agent (IBA)
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2005 - 01/2003
3
fluticasone (Cutivate)
FDA Link
Generic
06/2008 - 10/2004
2
Biological Markers (Surrogate Marker)
IBA
06/2008 - 06/2008
2
salmeterol (Serevent)
FDA Link
06/2008 - 01/2006
1
Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
IBA
09/2008
1
Particulate Matter
IBA
07/2008
1
Interleukin-6 (Interleukin 6)
IBA
01/2008
1
Smoke
IBA
07/2007
1
Steroids
IBA
03/2007
1
C-Reactive Protein
IBA
03/2006
1
Carbon Dioxide
IBA
02/2005
1
Glucocorticoids
IBA
07/2003
1
Universal
IBA
07/2003
Therapy/Procedure
1
Artificial Respiration (Mechanical Ventilation)
01/2007
1
Drug Therapy (Chemotherapy)
09/2006